COVID-19 is a serious health concern and the impact on our lives continues to evolve on a daily basis. In these unprecedented times, individuals with pre-existing conditions need to be especially careful. It is our goal to provide you with up-to-date information as it relates to this virus, and to help ease your mind during this challenging time.
The PKD Foundation of Canada was proud to present this complimentary webinar on June 4th 2020, How COVID-19 Affects the PKD Community. This webinar will gave our community the opportunity to ask questions to one of Canada’s leading ADPKD specialists.
Patients and their loved ones can view the live webinar recording to learn about the following topics and more:
The PKD Foundation of Canada was proud to present this complimentary webinar on June 4th 2020, How COVID-19 Affects the PKD Community. This webinar will gave our community the opportunity to ask questions to one of Canada’s leading ADPKD specialists.
Patients and their loved ones can view the live webinar recording to learn about the following topics and more:
- Am I more likely to get COVID-19 due to ADPKD?
- What should I do if I get COVID-19 and have ADPKD?
- How will treatment of ADPKD change during the COVID-19 pandemic?
Speaker: Dr Matthew Lanktree M.D.,Ph.D
You can view a live recording of this event below!
Presentation Recording
Q&A Segment Recording
About the Speaker :
You can view a live recording of this event below!
Presentation Recording
Q&A Segment Recording
About the Speaker :
Dr Matthew Lanktree M.D., Ph.D
Dr. Matthew Lanktree is a kidney doctor and scientist studying nephrology genetics, with special expertise in polycystic kidney disease, at St. Joseph’s Healthcare Hamilton and McMaster University. Dr. Lanktree is supported by the Canadian Institutes of Health Research, the Canadian and American Societies of Nephrology, the Kidney Foundation of Canada and “KRESCENT” our national kidney scientist training program. Dr. Lanktree has published over 60 articles in high impact journals in genetics and medicine. Dr. Lanktree has set his goal to use studies of our DNA to improve the care of patients with kidney disease.